We are live on ! Find out more
IA

IFP Advisors Portfolio holdings

AUM $5.54B
1-Year Est. Return 27.43%
This Fund
S&P 500
This Quarter Est. Return
+4.58%
1 Year Est. Return
+27.43%
3 Year Est. Return
+73.16%
5 Year Est. Return
+63.71%
10 Year Est. Return
AUM
$2.21B
AUM Growth
-$312M
Cap. Flow
-$405M
Cap. Flow %
-18.36%
Top 10 Hldgs %
15.84%
Holding
4,455
New
192
Increased
859
Reduced
2,110
Closed
499

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$16.1M
2
XOM icon
ExxonMobil
XOM
+$15.9M
3
T icon
AT&T
T
+$12.6M
4
AAPL icon
Apple
AAPL
+$11.8M
5
BP icon
BP
BP
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 5.44%
3 Healthcare 5.11%
4 Consumer Discretionary 4.03%
5 Industrials 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYGR icon
2726
Voyager Therapeutics
VYGR
$181M
$12K ﹤0.01%
750
+100
+15% +$1.71K
XNTK icon
2727
State Street SPDR NYSE Technology ETF
XNTK
$2B
$12K ﹤0.01%
138
MTUS icon
2728
Metallus
MTUS
$884M
$12K ﹤0.01%
789
-7,580
-91% -$115K
CDMO
2729
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$12K ﹤0.01%
3,043
-531
-15% -$2.27K
MDC
2730
DELISTED
M.D.C. Holdings, Inc.
MDC
$12K ﹤0.01%
433
-53
-11% -$1.46K
CPE
2731
DELISTED
Callon Petroleum Company
CPE
$12K ﹤0.01%
100
-115
-53% -$12.7K
LONE
2732
DELISTED
Lonestar Resources US Inc. Class A Common Stock
LONE
$12K ﹤0.01%
3,100
CCMP
2733
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$12K ﹤0.01%
126
+3
+2% +$276
CHK
2734
PUT
DELISTED
Chesapeake Energy Corporation
CHK
$12K ﹤0.01%
15
BOLD
2735
DELISTED
Audentes Therapeutics, Inc
BOLD
$12K ﹤0.01%
400
GNCA
2736
DELISTED
Genocea Biosciences, Inc.
GNCA
$12K ﹤0.01%
1,269
ENLK
2737
DELISTED
EnLink Midstream Partners, LP
ENLK
$12K ﹤0.01%
774
-2,350
-75% -$36.9K
EDR
2738
DELISTED
Education Realty Trust Inc
EDR
$12K ﹤0.01%
332
+117
+54% +$4.22K
KND
2739
DELISTED
Kindred Healthcare
KND
$12K ﹤0.01%
1,200
-102
-8% -$759
KMM
2740
DELISTED
Deutsche Multi-Market Incm Trust
KMM
$12K ﹤0.01%
1,361
FTR
2741
DELISTED
Frontier Communications Corp.
FTR
$12K ﹤0.01%
1,804
-4,552
-72% -$42.5K
CHA
2742
DELISTED
China Telecom Corporation, LTD
CHA
$12K ﹤0.01%
245
-6
-2% -$299
VXX
2743
CALL
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$12K ﹤0.01%
+400
New +$13.2K
STL
2744
DELISTED
Sterling Bancorp
STL
$12K ﹤0.01%
502
ACHC icon
2745
Acadia Healthcare
ACHC
$2.95B
$11K ﹤0.01%
327
-279
-46% -$9.67K
AIT icon
2746
Applied Industrial Technologies
AIT
$12.8B
$11K ﹤0.01%
155
APAM icon
2747
Artisan Partners
APAM
$2.91B
$11K ﹤0.01%
282
-300
-52% -$11.1K
AXON
2748
Axon Enterprise
AXON
$43.5B
$11K ﹤0.01%
420
-12,900
-97% -$310K
BKU icon
2749
Bankunited
BKU
$3.41B
$11K ﹤0.01%
275
-137
-33% -$4.99K
BTT icon
2750
BlackRock Municipal 2030 Target Term Trust
BTT
$1.43B
$11K ﹤0.01%
507
-1,020
-67% -$22.9K

Similar funds

IFP Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, IFP Advisors held 4,455 positions worth $2.21B, down 12% from $2.52B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

IFP Advisors withdrew a net $405M in Q4 2017, closing 499 positions and reducing 2,110 holdings. Its most notable exit was ProShares Large Cap Core Plus, an estimated $2.47M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.

Against the trend, IFP Advisors opened a new position in DuPont de Nemours worth $4.1M.

  • IFP Advisors's largest Q4 2017 buy was DuPont de Nemours: 22,718 shares worth $4.1M.
  • IFP Advisors added most to iShares Biotechnology ETF in Q4 2017, an estimated $5.08M increase.
  • IFP Advisors's biggest Q4 2017 reduction was Procter & Gamble, cutting an estimated $16.1M.
  • IFP Advisors fully exited ProShares Large Cap Core Plus in Q4 2017, selling an estimated $2.47M.
  • IFP Advisors's ten largest holdings make up 16% of its $2.21B portfolio in Q4 2017.
  • IFP Advisors opened 192 new positions and closed 499 in Q4 2017.
  • IFP Advisors's portfolio value fell 12% quarter-over-quarter to $2.21B.

Based on IFP Advisors's 13F filing for Q4 2017, filed 24 Jan 2018.